News

Category: JOM

JOM

Successful buprenorphine transition while overlapping with a full opioid agonist to treat chronic pain: a case report

Buprenorphine is a partial mu opioid agonist that has been increasingly utilized to treat patients with chronic pain and opioid use disorder (OUD). The drug has proven to provide significant chronic pain relief at low doses ranging from 75 to 1800 mcg.

JOM Staff

01.03.23

JOM

January 2023 issue of Journal of Osteopathic Medicine now available

In the January issue of Journal of Osteopathic Medicine (JOM), you’ll find a lineup of articles across various subspecialty areas and topics, including a review of commercially available rapid influenza diagnostic tests, an expert commentary on traumatic brain injury care and research, the role of osteopathic manipulative medicine for college athletes recovering from a concussion, … Read More

JOM Staff

01.01.23

JOM

The groove sign

A 26-year-old man presented to a rheumatology clinic in October 2021 with complaints of recurrent polyarticular joint pain and decreased flexibility. Three years prior he was diagnosed with eosinophilic fasciitis and had minimal symptoms after treatment with methotrexate, prompting discontinuation of his medications. One year later he had recurrence of joint pain and skin tightness. He … Read More

JOM Staff

12.19.22

JOM

Subcutaneous Sweet’s syndrome: a rare subtype of acute febrile neutrophilic dermatosis

A 58-year-old woman presented to the hospital in July 2021 with a 2 month history of night sweats and a sudden painful cutaneous eruption on the bilateral dorsal forearms. She denied additional systemic symptoms including arthralgia, fatigue, and weight loss.

JOM Staff

12.17.22

JOM

Acute pericarditis confirmed by coronary computed tomography angiogram

A 48-year-old man with a history of hypertension (for the past 10 years on metoprolol succinate and triamterene-hydrochlorothiazide), asthma (for the past 15 years on albuterol and fluticasone inhalers), and prior tobacco abuse (30 pack-year, quit in May 2010) presented in October 2021 with progressively worsening left-sided chest pain. The chest pain suddenly started approximately 24 h prior … Read More

JOM Staff

12.15.22

JOM

Casirivimab/imdevimab treatment for outpatient COVID-19 during a SARS-CoV-2 B1.617.2 (Delta) surge at a community hospital

Vaccination status has been shown to be linked to patient-centered outcomes in those with COVID-19. However, minimal data have explored the relationship between vaccination status and representation rates after receiving monoclonal antibodies (MABs) the Delta strain of severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) in a community setting.

JOM Staff

12.13.22

JOM

Pain and functional recovery from chronic low back pain over 12 months: implications for osteopathic medicine

Although low back pain is a common medical condition that often progresses to become a chronic problem, little is known about the likelihood of recovery from chronic low back pain (CLBP).

JOM Staff

12.11.22

JOM

Chronic exertional compartment syndrome in a patient with restrictive cardiomyopathy and portal hypertension

Chronic exertional compartment syndrome (CECS) is a condition that produces exercise-induced pain and swelling due to a transient increase in compartment pressures. It is thought to be due to muscle hypertrophy and is classically associated with young athletes under 30, overtraining, anabolic steroid use, and aberrant running biomechanics.

JOM Staff

12.09.22

JOM

The effect of the COVID-19 pandemic on osteopathic education in ACGME-OR residencies from February 2020 to February 2021

It remains to be determined exactly how the COVID-19 pandemic has and will continue to impact osteopathic resident education, in particular as it pertains to treatment with osteopathic manipulative medicine (OMM). Although the long-term effects of the pandemic cannot be determined yet, changes in current resident education can be analyzed.

JOM Staff

12.07.22